Magnetic brain stimulation shows promise for Parkinson's symptoms

NCT ID NCT07554833

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether an accelerated course of repetitive transcranial magnetic stimulation (rTMS) can improve movement and thinking in people with mild to moderate Parkinson's disease. Forty participants aged 50 to 90 will receive six sessions of high-frequency magnetic pulses to the motor cortex over three weeks. Researchers will measure changes in motor symptoms, cognitive function, and quality of life up to three months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
repetitive transcranial magnetic stimulation (rTMS) using the EXOMIND™ device
What this could lead to
If it works, this could point toward a non-drug treatment option that eases both movement and thinking problems in Parkinson's disease.
What could go wrong
This is a small, early pilot study with no placebo group, so results may not be reliable. The treatment is experimental and may not provide lasting benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • San Francisco Neurology and Sleep Center

    RECRUITING

    San Francisco, California, 94108, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.